Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

In the evolving field of cancer biology and treatment, innovations in organ-on-a-chip microdevices allow researchers to discover more about the disease outside the human body.

23 Jul 2021

Study: Women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing

A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing.

22 Jul 2021

Protein involved in cell migration offers clues to cancer metastases

A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumors, according to new research from the University of Warwick.

21 Jul 2021

Selective immunotoxins may help treat liver fibrosis

Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

12 Jul 2021

New study to test the scalability of offering preventive DNA screening to young adults for cancer risk

A landmark new DNA screening study to identify cancer risk in young adults will go ahead, after Monash University researcher Associate Professor Paul Lacaze was awarded a $2.97 million Medical Research Future Fund (MRFF) grant today.

2 Jul 2021

World-first study uses artificial intelligence to map the risks of ovarian cancer in women

The University of South Australia will lead a world-first study, using artificial intelligence, to map the risks of the most fatal reproductive cancer in women worldwide so it can be detected and treated earlier.

2 Jul 2021

Mutation-signature–associated metrics predict cancer progression in patients

Oncotarget published "Predicting clinical outcomes using cancer progression associated signatures" which reported somatic mutation signatures are an informative facet of cancer etiology, however they are rarely useful for predicting patient outcome.

28 Jun 2021

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC, Inc. announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM) and other high-grade glioma (HGG) patients.

18 Jun 2021

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass.

11 Jun 2021

Study shows how XRCC1 gene untangles proteins that trigger cancerous tumors

Even on a good day, DNA is constantly getting damaged. Nicks, scratches, breaks: the delicate strands that carry life's genetic code take a beating as they jumble about in the course of their work. If left untreated, errors accumulate, with fatal consequences -- such as cancerous tumors -- for the cell and the organism.

11 Jun 2021

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers at the University of Pennsylvania and Penn's Perelman School of Medicine.

1 Jun 2021

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards.

28 May 2021

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Carpal tunnel syndrome (CTS), which causes tingling and numbness in the hand, more commonly affects women than men and tends to peak around the age of menopause.

26 May 2021

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

A new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals.

18 May 2021

Early detection of ovarian cancer does not translate into saving lives

Researchers in the UK have established that although a method of screening can detect ovarian cancer early and before women develop symptoms, it does not translate into saving lives.

17 May 2021

Risk prediction model does not accurately identify lung cancer risks in diverse population

Lung cancer is the third most common cancer in the U.S. and the leading cause of cancer death, with about 80% of the total 154,000 deaths recorded each year caused by cigarette smoking. Black men are more likely to develop and die from lung cancer than persons of any other racial or ethnic group, pointing to severe racial disparities.

5 May 2021

New drug class effective in treating certain types of ovarian cancers

A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.

4 May 2021

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Researchers develop ovarian tumor microenvironment-chip to test novel ways to treat the disease

Study: Women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing

Protein involved in cell migration offers clues to cancer metastases

Selective immunotoxins may help treat liver fibrosis

New study to test the scalability of offering preventive DNA screening to young adults for cancer risk

World-first study uses artificial intelligence to map the risks of ovarian cancer in women

Mutation-signature–associated metrics predict cancer progression in patients

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer

Study shows how XRCC1 gene untangles proteins that trigger cancerous tumors

Odor-based test could serve as a non-invasive approach to screen for harder-to-detect cancers

New biomarker could be used to determine resistance of ovarian cancer to platinum chemotherapy

Postmenopausal women who underwent bilateral oophorectomy have increased risk of carpal tunnel syndrome

Breast cancer survivors have higher risk of new cancer diagnosis compared to healthy individuals

Early detection of ovarian cancer does not translate into saving lives

Risk prediction model does not accurately identify lung cancer risks in diverse population

New drug class effective in treating certain types of ovarian cancers

Rucaparib drug is effective in treating certain types of ovarian cancers, shows study

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in